Clarifying the role of teriparatide in kidney transplant recipients with low bone turnover, osteoporosis, and high fracture risk
Crossref DOI link: https://doi.org/10.1007/s11255-025-04654-4
Published Online: 2025-09-20
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Vetrano, Daniele
La Manna, Gaetano
Cianciolo, Giuseppe
Text and Data Mining valid from 2025-09-20
Version of Record valid from 2025-09-20
Article History
Received: 12 June 2025
Accepted: 6 July 2025
First Online: 20 September 2025
Declarations
:
: The authors declare no competing interests.